TY - JOUR
T1 - Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity
AU - Santoni, A.
AU - Piccoli, M.
AU - Ortaldo, J. R.
AU - Mason, L.
AU - Wiltrout, R. H.
AU - Herberman, R. B.
PY - 1985
Y1 - 1985
N2 - NK activity of mice as well as humans and rats has been clearly associated with large granular lymphocytes (LGL). To better understand the effects of interferon (IFN) and IFN inducers on natural killer (NK) cells, we have compared the LGL in the spleens of normal and boosted mice. Cells were fractionated by centrifugation on discontinuous Percoll density gradients, and each fraction was tested for NK activity against YAC-1 targets and for the presence of LGL. In vivo treatment with C. parvum (0.7 mg/mouse, i.p., day -3), MVE-2 (25 mg/kg i.p., day -3), poly I:C (4 mg/kg i.p., day -3), or IFN (105 U/mouse, i.p., day -1) resulted in a marked augmentation and a change of distribution of cytototix activity. Most of the NK activity of boosted spleen cells was associated with lower density fractions 1 and 2, whereas active normal spleen cells had somewhat higher density (fractions 2 and 3). In parallel to their increased reactivity, the boosted spleens had a marked increase in the percentage of LGL, particularly in fractions 1 and 2. The augmented activity appeared to be mediated by the LGL, because treatment with anti-asialo GM1 or anti-Thy-1.2 plus complement reduced NK as well as the number of LGL. These results indicate that IFN-mediated boosting of NK activity in the spleen is due to an increase in the lower density LGL, as well as to an increase in the function of preexisting NK cells.
AB - NK activity of mice as well as humans and rats has been clearly associated with large granular lymphocytes (LGL). To better understand the effects of interferon (IFN) and IFN inducers on natural killer (NK) cells, we have compared the LGL in the spleens of normal and boosted mice. Cells were fractionated by centrifugation on discontinuous Percoll density gradients, and each fraction was tested for NK activity against YAC-1 targets and for the presence of LGL. In vivo treatment with C. parvum (0.7 mg/mouse, i.p., day -3), MVE-2 (25 mg/kg i.p., day -3), poly I:C (4 mg/kg i.p., day -3), or IFN (105 U/mouse, i.p., day -1) resulted in a marked augmentation and a change of distribution of cytototix activity. Most of the NK activity of boosted spleen cells was associated with lower density fractions 1 and 2, whereas active normal spleen cells had somewhat higher density (fractions 2 and 3). In parallel to their increased reactivity, the boosted spleens had a marked increase in the percentage of LGL, particularly in fractions 1 and 2. The augmented activity appeared to be mediated by the LGL, because treatment with anti-asialo GM1 or anti-Thy-1.2 plus complement reduced NK as well as the number of LGL. These results indicate that IFN-mediated boosting of NK activity in the spleen is due to an increase in the lower density LGL, as well as to an increase in the function of preexisting NK cells.
UR - http://www.scopus.com/inward/record.url?scp=0021926287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021926287&partnerID=8YFLogxK
M3 - Article
C2 - 2579157
AN - SCOPUS:0021926287
SN - 0022-1767
VL - 134
SP - 2799
EP - 2810
JO - Journal of Immunology
JF - Journal of Immunology
IS - 4
ER -